Pmn clinical trials

Explore recruiting pmn clinical trials.

Recruiting pmn studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pmn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER)

Germany, France, Italy, Spain, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b/3 Adaptive, Randomized, Active controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy

Hungary, Ireland, Czechia, Italy, Spain, Germany +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants with PMN (Primary Membranous Nephropathy) who are at a High Risk for Disease Progression (AUTUMN)

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Surovatamig in Adults with Antibody-mediated Kidney Disease

France, Italy, Belgium, Poland, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy

Poland, Italy, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2-arm parallel-group, double-blind, placebo-controlled basket trial to assess safety, tolerability, PK, and efficacy of BI 764198 in four proteinuric kidney diseases

Portugal, Greece, Italy, Poland, Estonia, Slovakia +10 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Pmn trials by city

Pmn in Toronto Pmn in Vancouver Pmn in Montreal Pmn in Calgary Pmn in Edmonton Pmn in Ottawa Pmn in Winnipeg Pmn in Quebec City Pmn in Hamilton Pmn in Kitchener Pmn in London Pmn in Halifax Pmn in New York Pmn in Los Angeles Pmn in Chicago Pmn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease